Holen Sie sich die Stockscreener-App
1.67
7.05%
0.11
Vorhandelsmarkt:
1.68
0.01
+0.60%
Schlusskurs vom Vortag:
$1.56
Offen:
$1.58
24-Stunden-Volumen:
249.69K
Relative Volume:
0.23
Marktkapitalisierung:
$6.02M
Einnahmen:
$418.20K
Nettoeinkommen (Verlust:
$-46.90M
KGV:
-0.069
EPS:
-24.1892
Netto-Cashflow:
$-29.84M
1W Leistung:
+15.17%
1M Leistung:
-35.52%
6M Leistung:
-64.22%
1J Leistung:
-87.42%
1-Tages-Spanne:
$1.54
$1.76
1-Wochen-Bereich:
$1.38
$1.76
52-Wochen-Spanne:
$1.35
$3.95
Co Diagnostics Inc Stock (CODX) Company Profile
Firmenname
Co Diagnostics Inc
Sektor
Branche
Telefon
(801) 438-1036
Adresse
2401 S FOOTHILL DRIVE, SALT LAKE CITY
Compare CODX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
1.67 | 5.62M | 418.20K | -46.90M | -29.84M | -24.19 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-12 | Herabstufung | Sidoti | Buy → Neutral |
| 2021-12-29 | Eingeleitet | Sidoti | Buy |
| 2021-03-29 | Herabstufung | Maxim Group | Buy → Hold |
| 2020-05-20 | Hochstufung | Maxim Group | Hold → Buy |
| 2020-05-18 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-09 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-03 | Herabstufung | Maxim Group | Buy → Hold |
Alle ansehen
Co Diagnostics Inc Aktie (CODX) Neueste Nachrichten
Co-Diagnostics (CODX) price target decreased by 37.50% to 1.28 - MSN
Co-Diagnostics (CODX) price target decreased by 20.00% to 30.60 - MSN
symbol__ Stock Quote Price and Forecast - CNN
Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C. - BioSpace
Tuberculosis test heads to Washington summit as Co-Diagnostics joins TB push - Stock Titan
Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany - Financial Times
Investment Review: What analysts say about Co Diagnostics Inc stockProfit Target & Daily Volume Surge Trade Alerts - baoquankhu1.vn
CODX Technical Analysis | Trend, Signals & Chart Patterns | CO-DIAGNOSTICS INC (NASDAQ:CODX) - ChartMill
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah - BioSpace
Co-Diagnostics Executives to Participate in European Trade Missi - GuruFocus
Portfolio Update: Is Co Diagnostics Inc benefiting from interest rate changesMarket Movement Recap & Low Risk High Reward Ideas - baoquankhu1.vn
Utah trade mission puts Co-Diagnostics in meetings with Roche, UBS - Stock Titan
Aug Drivers: Can Co Diagnostics Inc scale operations efficientlyWatch List & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Bull Bear: What analysts say about Co Diagnostics Inc stockTrade Risk Assessment & Real-Time Stock Entry Alerts - baoquankhu1.vn
COVID-19 Detection Kits Market Set to Boom Rapidly by 2033 | - openPR.com
Co-Diagnostics Q4 2025 earnings preview - MSN
Co-Diagnostics, Inc. (CODX) stock price, news, quote and history - uk.finance.yahoo.com
Co-Diagnostics Earnings Call: Pipeline Progress, Cash Strain - TipRanks
Q4 2025 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
Co-Diagnostics Joint Venture to Build Molecular Diagnostics Facility in Saudi Arabia - Clinical Lab Products
Co-Diagnostics Joint Venture Comira Receives Approval For Manufacturing Facility In Kingdom Of Saudi Arabia's Sudair Industrial City - TradingView — Track All Markets
Co-Diagnostics, Inc.'s joint venture Comira has officially received approval to establish a manufacturing facility in Sudair Industrial City, Kingdom of Saudi Arabia. - Bitget
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City - The Herald Journal
Co-Diagnostics reports operating loss of USD 50.2M in 2025 - Medical Buyer
Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2025 Earnings Call Transcript - Insider Monkey
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City – Company AnnouncementFT.com - Financial Times
This diagnostics company is advancing a global expansion strategy, positioning for growth phase - MSN
Co-Diagnostics Expands South Asia Footprint, Targeting $13B Diagnostics Opportunity - USA Today
Exclusive: Co-Diagnostics ships diagnostic tests to India ahead of TB study launch - MSN
Co-Diagnostics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Stra - gurufocus.com
Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Strategic Expansions and Financial ... By GuruFocus - Investing.com Canada
Co-Diagnostics Inc (CODX) Q4 2025 Earnings Call Highlights: Strategic Expansions and Financial ... - Yahoo Finance
Co-Diagnostics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Co-Diagnostics Q4 2025 sees mixed results, stock up 12% - Investing.com India
Co-Diagnostics Reports Full Year 2025 Financial Results - GuruFocus
Earnings call transcript: Co-Diagnostics Q4 2025 sees mixed results, stock up 12% By Investing.com - Investing.com South Africa
CODX: Revenue fell, losses widened, but global expansion and regulatory progress drive future growth - TradingView — Track All Markets
This Diagnostics Company Is Advancing a Global Expansion Strategy, Positioning for Growth Phase - The Globe and Mail
CODX: Revenue fell, but global expansion and clinical progress set the stage for future growth - TradingView
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Co-Diagnostics (CODX) Releases Q4 2025 Earnings: Revenue Down, Net Loss Widens - Quiver Quantitative
Co-Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Co-Diagnostics (NASDAQ: CODX) warns on going concern while advancing PCR platform - Stock Titan
Co-Diagnostics (NASDAQ: CODX) 2025 revenue plunges as cash declines - Stock Titan
Press Release: Co-Diagnostics Reports Full Year 2025 Financial Results - 富途牛牛
Co-Diagnostics, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Finanzdaten der Co Diagnostics Inc-Aktie (CODX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):